Whitehawk Therapeutics to Present at the Jefferies 2026 Global Healthcare Conference
Whitehawk Therapeutics (Nasdaq: WHWK) announced that President and CEO Dave Lennon, PhD, will present at the Jefferies 2026 Global Healthcare Conference in New York City on Thursday, June 4 at 8:10 AM ET.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Whitehawk Therapeutics (Nasdaq: WHWK) announced that President and CEO Dave Lennon, PhD, will present at the Jefferies 2026 Global Healthcare Conference in New York City on Thursday, June 4 at 8:10 AM ET.
A live and replay webcast will be available on the company’s IR website for ~30 days.
Details
News Market Reaction – WHWK
On May 29, the first trading day after this news, WHWK closed 1.26% below the previous close.
Data tracked by StockTitan Argus for the May 29 session.
Key Figures
- Conference date
- June 4, 2026
- Jefferies 2026 Global Healthcare Conference presentation
- Presentation time
- 8:10 AM ET
- Scheduled time for Jefferies conference fireside chat
- Webcast replay period
- 30 days
- Approximate duration replay will be available on IR website
Historical Context
-
Expanded access to CPT113 linker-payload for up to five ADC programs.
-
CEO fireside chat at TD Cowen oncology innovation summit.
-
Announcement of virtual fireside chat at Stifel oncology forum.
-
Approximately $87.5M private placement to extend cash runway into 2H 2028.
-
Q1 2026 results with higher R&D spend and a $22.2M net loss.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Key Terms
antibody drug conjugate medical
AI-generated analysis. How Rhea-AI works. Not financial advice.
A live webcast of the fireside chat can be accessed by visiting the Whitehawk Therapeutics IR website and will be available for replay for approximately 30 days following the event.
About Whitehawk Therapeutics
Whitehawk Therapeutics is a clinical-stage oncology therapeutics company applying advanced technologies to established tumor biology to efficiently deliver improved cancer treatments. Whitehawk's advanced three-asset ADC portfolio is engineered to overcome the limitations of first-generation predecessors to deliver a meaningful impact for patients with difficult-to-treat cancers. These assets are in-licensed from
Contact:
IR@whitehawktx.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/whitehawk-therapeutics-to-present-at-the-jefferies-2026-global-healthcare-conference-302784951.html
SOURCE Whitehawk Therapeutics, Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.